Home / Cancer and immune system / Pralatrexate
ATC L01BA05 · Folic Acid Analogues · updated 2 Nov 2026
Pralatrexate shortage
As of 2 Nov 2026, Pralatrexate has a reported shortage in 1 of the 16 countries we track (Australia), covering 1 product from 0 companies.
Is there a Pralatrexate shortage?
Yes. As of 2 Nov 2026, Pralatrexate is reported short in 1 of the 16 countries we track: Australia. The earliest expected return is 6 Nov 2026 (Australia). New since 3 Oct 2026: Australia.
Timeline
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Compared with similar medicines
ATC group L01BA · Folic Acid AnaloguesAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AU | FOLOTYN pralatrexate 20 mg/1 mL injection, intravenous infusion vial | 12 Oct 2026 | 6 Nov 2026 | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there a Pralatrexate shortage?
Yes. As of 2 Nov 2026, Pralatrexate is reported short in 1 of the 16 countries we track: Australia. The earliest expected return is 6 Nov 2026 (Australia). New since 3 Oct 2026: Australia.
When will Pralatrexate be back in stock?
Companies expect supply back from 6 Nov 2026 in Australia; Australia: 6 Nov 2026. These are company estimates reported to each authority.
Why is Pralatrexate in short supply?
The most common reason reported is: not stated. Reasons by product are listed in the table below.
Which companies have Pralatrexate shortages?
The registers do not name the companies.